Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Indegene Q4 net profit falls 32% despite record ₹1,003 crore revenue, declares dividend
Shares of Indegene Ltd ended at ₹497.70, down by ₹2.05, or 0.41%, on the BSE.
Q4 Results Highlights: Indegene profit falls 32%, RPG Life revenue up 24%
Q4 Results Highlights: Major companies including Bajaj Finance, Adani Power, Vedanta, MOIL, Mphasis, Navin Fluorine, Waaree Energies and Bandhan Bank reported their Q4 earnings on Wednesday, while a host of financial, energy and midcap firms also announced results, keeping markets active ahead of a holiday-shortened week.
Neutral Indegene; target of Rs 552: Motilal Oswal
Motilal Oswal recommended Neutral rating on Indegene with a target price of Rs 552 in its research report dated May 02, 2026.
Buy Indegene; target of Rs 620: ICICI Securities
ICICI Securities is bullish on Indegene has recommended buy rating on the stock with a target price of Rs 620 in its research report dated May 02, 2026.
Indegene targets larger share of pharma marketing spend through acquisitions, AI
The shift from the traditional pharma commercialisation model built around large sales forces, fragmented advertising agency networks and brand-by-brand marketing is giving way to centralised, data-driven and digital-first engagement, Indegene chief financial officer Suhas Prabhu tells Moneycontrol